피부 마이크로바이옴 조절제 : 세계 시장 점유율과 순위, 총판매량 및 수요 예측(2025-2031년)

The global market for Skin Microbiome Modulator was estimated to be worth US$ 792 million in 2024 and is forecast to a readjusted size of US$ 1961 million by 2031 with a CAGR of 13.8% during the forecast period 2025-2031.

Skin microbiome regulators refer to a class of functional substances or products that maintain or restore the balance of skin microecology by regulating the composition, structure and metabolic activity of the microbial community on the skin surface, thereby improving or enhancing the health of the skin. Such regulators include probiotics, prebiotics, postbiotics, microecological metabolites, natural plant extracts, etc., which can promote the growth of beneficial bacteria, inhibit pathogenic microorganisms, enhance skin barrier function and regulate immune response. They are suitable for multiple skin care fields such as anti-inflammatory, anti-allergic, anti-acne, and anti-aging. With the in-depth understanding of the relationship between skin microecology and skin diseases, skin microbiome regulators have become an important direction of modern dermatology, cosmetic development and personalized skin care, and have been widely used in medical skin care and functional cosmetics.

Skin microbiome regulators are gradually becoming an emerging focus in the field of skin care technology. They help maintain or restore the balance of the microecology by regulating the microbial community on the surface of the skin, thereby improving the skin barrier function and overall health. At present, such regulators can be mainly divided into three categories: probiotics (such as active microorganisms such as Lactobacillus and Staphylococcus epidermidis), which can directly act on the skin microecology; prebiotics (such as oligofructose, inulin, etc.), which promote the reproduction and colonization of beneficial bacteria by providing nutrition for them; and pharmaceutical regulators, including antimicrobial peptides, microecological targeting molecules, etc., are more used to specifically inhibit pathogenic bacteria or regulate immune responses. These regulators have been widely used in skin care products (such as anti-inflammatory, anti-acne, anti-allergic, and moisturizing facial skin care products), hair care products (such as scalp soothing, oil control, and anti-hair loss products), and gradually expanded to "other" high-potential scenarios such as medical-assisted skin care, infant care, men's care, and postoperative repair.

The core manufacturers of global skin microbiome regulators include L'Oreal S.A., Unilever and The Estee Lauder Companies, etc. The top three manufacturers account for about 27% of the global market share. The Americas is the world's largest market, accounting for about 33% of the market share, followed by Asia Pacific and Europe, accounting for 32% and 26% respectively.

With the deepening integration of microbiome, synthetic biology and skin science, skin microbiome regulators will develop in a more precise, personalized and intelligent direction in the future. For example, customizing personalized regulation plans through AI analysis of individual skin microecological status, or developing a controlled release live bacteria delivery system, will become a breakthrough in the industry. At the same time, with the increase in consumers' dual demands for "effective skin care" and "natural safety", regulator products must also take into account scientific verification and green sustainability.

In this wave of development, manufacturers should actively change their roles from a simple raw material supplier to a microecological solution provider. On the one hand, we should increase basic research on the skin microecological mechanism, flora interaction, and regulator efficacy mechanism, and promote clinical efficacy verification and the construction of a standardized evaluation system; on the other hand, we should explore diversified product forms (such as freeze-dried powder, encapsulated microcapsules, and instant activation preparations) to improve ease of use and ingredient stability. In addition, manufacturers should also pay attention to regulatory trends and industry standard formulation, strengthen cooperation with brand owners and scientific research institutions, lay out intellectual property and patent pools, build new competitive advantages with microecological skin care as the core, and promote the true transformation of skin microbiome regulators from technical concepts to large-scale product markets.

This report aims to provide a comprehensive presentation of the global market for Skin Microbiome Modulator, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Skin Microbiome Modulator by region & country, by Type, and by Application.

The Skin Microbiome Modulator market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Skin Microbiome Modulator.

Market Segmentation

By Company

• L'Oreal
• Unilever
• The Estee Lauder Companies
• Johnson & Johnson
• Revlon
• Evelo Biosciences
• AOBiome
• Azitra
• GALLINEE
• Glowbiotics

Segment by Type

• Probiotics
• Prebiotics
• Drugs

Segment by Application

• Skin Care
• Hair Care
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Skin Microbiome Modulator company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Skin Microbiome Modulator in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Skin Microbiome Modulator in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Skin Microbiome Modulator Product Introduction
• 1.2 Global Skin Microbiome Modulator Market Size Forecast (2020-2031)
• 1.3 Skin Microbiome Modulator Market Trends & Drivers
  • 1.3.1 Skin Microbiome Modulator Industry Trends
  • 1.3.2 Skin Microbiome Modulator Market Drivers & Opportunity
  • 1.3.3 Skin Microbiome Modulator Market Challenges
  • 1.3.4 Skin Microbiome Modulator Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Skin Microbiome Modulator Players Revenue Ranking (2024)
• 2.2 Global Skin Microbiome Modulator Revenue by Company (2020-2025)
• 2.3 Key Companies Skin Microbiome Modulator Manufacturing Base Distribution and Headquarters
• 2.4 Key Companies Skin Microbiome Modulator Product Offered
• 2.5 Key Companies Time to Begin Mass Production of Skin Microbiome Modulator
• 2.6 Skin Microbiome Modulator Market Competitive Analysis
  • 2.6.1 Skin Microbiome Modulator Market Concentration Rate (2020-2025)
  • 2.6.2 Global 5 and 10 Largest Companies by Skin Microbiome Modulator Revenue in 2024
  • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin Microbiome Modulator as of 2024)
• 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Probiotics
  • 3.1.2 Prebiotics
  • 3.1.3 Drugs
• 3.2 Global Skin Microbiome Modulator Sales Value by Type
  • 3.2.1 Global Skin Microbiome Modulator Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Skin Microbiome Modulator Sales Value, by Type (2020-2031)
  • 3.2.3 Global Skin Microbiome Modulator Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Skin Care
  • 4.1.2 Hair Care
  • 4.1.3 Others
• 4.2 Global Skin Microbiome Modulator Sales Value by Application
  • 4.2.1 Global Skin Microbiome Modulator Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Skin Microbiome Modulator Sales Value, by Application (2020-2031)
  • 4.2.3 Global Skin Microbiome Modulator Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

• 5.1 Global Skin Microbiome Modulator Sales Value by Region
  • 5.1.1 Global Skin Microbiome Modulator Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Skin Microbiome Modulator Sales Value by Region (2020-2025)
  • 5.1.3 Global Skin Microbiome Modulator Sales Value by Region (2026-2031)
  • 5.1.4 Global Skin Microbiome Modulator Sales Value by Region (%), (2020-2031)
• 5.2 North America
  • 5.2.1 North America Skin Microbiome Modulator Sales Value, 2020-2031
  • 5.2.2 North America Skin Microbiome Modulator Sales Value by Country (%), 2024 VS 2031
• 5.3 Europe
  • 5.3.1 Europe Skin Microbiome Modulator Sales Value, 2020-2031
  • 5.3.2 Europe Skin Microbiome Modulator Sales Value by Country (%), 2024 VS 2031
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Skin Microbiome Modulator Sales Value, 2020-2031
  • 5.4.2 Asia Pacific Skin Microbiome Modulator Sales Value by Region (%), 2024 VS 2031
• 5.5 South America
  • 5.5.1 South America Skin Microbiome Modulator Sales Value, 2020-2031
  • 5.5.2 South America Skin Microbiome Modulator Sales Value by Country (%), 2024 VS 2031
• 5.6 Middle East & Africa
  • 5.6.1 Middle East & Africa Skin Microbiome Modulator Sales Value, 2020-2031
  • 5.6.2 Middle East & Africa Skin Microbiome Modulator Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Skin Microbiome Modulator Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Skin Microbiome Modulator Sales Value, 2020-2031
• 6.3 United States
  • 6.3.1 United States Skin Microbiome Modulator Sales Value, 2020-2031
  • 6.3.2 United States Skin Microbiome Modulator Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Skin Microbiome Modulator Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Skin Microbiome Modulator Sales Value, 2020-2031
  • 6.4.2 Europe Skin Microbiome Modulator Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Skin Microbiome Modulator Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Skin Microbiome Modulator Sales Value, 2020-2031
  • 6.5.2 China Skin Microbiome Modulator Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Skin Microbiome Modulator Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Skin Microbiome Modulator Sales Value, 2020-2031
  • 6.6.2 Japan Skin Microbiome Modulator Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Skin Microbiome Modulator Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Skin Microbiome Modulator Sales Value, 2020-2031
  • 6.7.2 South Korea Skin Microbiome Modulator Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Skin Microbiome Modulator Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Skin Microbiome Modulator Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Skin Microbiome Modulator Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Skin Microbiome Modulator Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Skin Microbiome Modulator Sales Value, 2020-2031
  • 6.9.2 India Skin Microbiome Modulator Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Skin Microbiome Modulator Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 L'Oreal
  • 7.1.1 L'Oreal Profile
  • 7.1.2 L'Oreal Main Business
  • 7.1.3 L'Oreal Skin Microbiome Modulator Products, Services and Solutions
  • 7.1.4 L'Oreal Skin Microbiome Modulator Revenue (US$ Million) & (2020-2025)
  • 7.1.5 L'Oreal Recent Developments
• 7.2 Unilever
  • 7.2.1 Unilever Profile
  • 7.2.2 Unilever Main Business
  • 7.2.3 Unilever Skin Microbiome Modulator Products, Services and Solutions
  • 7.2.4 Unilever Skin Microbiome Modulator Revenue (US$ Million) & (2020-2025)
  • 7.2.5 Unilever Recent Developments
• 7.3 The Estee Lauder Companies
  • 7.3.1 The Estee Lauder Companies Profile
  • 7.3.2 The Estee Lauder Companies Main Business
  • 7.3.3 The Estee Lauder Companies Skin Microbiome Modulator Products, Services and Solutions
  • 7.3.4 The Estee Lauder Companies Skin Microbiome Modulator Revenue (US$ Million) & (2020-2025)
  • 7.3.5 The Estee Lauder Companies Recent Developments
• 7.4 Johnson & Johnson
  • 7.4.1 Johnson & Johnson Profile
  • 7.4.2 Johnson & Johnson Main Business
  • 7.4.3 Johnson & Johnson Skin Microbiome Modulator Products, Services and Solutions
  • 7.4.4 Johnson & Johnson Skin Microbiome Modulator Revenue (US$ Million) & (2020-2025)
  • 7.4.5 Johnson & Johnson Recent Developments
• 7.5 Revlon
  • 7.5.1 Revlon Profile
  • 7.5.2 Revlon Main Business
  • 7.5.3 Revlon Skin Microbiome Modulator Products, Services and Solutions
  • 7.5.4 Revlon Skin Microbiome Modulator Revenue (US$ Million) & (2020-2025)
  • 7.5.5 Revlon Recent Developments
• 7.6 Evelo Biosciences
  • 7.6.1 Evelo Biosciences Profile
  • 7.6.2 Evelo Biosciences Main Business
  • 7.6.3 Evelo Biosciences Skin Microbiome Modulator Products, Services and Solutions
  • 7.6.4 Evelo Biosciences Skin Microbiome Modulator Revenue (US$ Million) & (2020-2025)
  • 7.6.5 Evelo Biosciences Recent Developments
• 7.7 AOBiome
  • 7.7.1 AOBiome Profile
  • 7.7.2 AOBiome Main Business
  • 7.7.3 AOBiome Skin Microbiome Modulator Products, Services and Solutions
  • 7.7.4 AOBiome Skin Microbiome Modulator Revenue (US$ Million) & (2020-2025)
  • 7.7.5 AOBiome Recent Developments
• 7.8 Azitra
  • 7.8.1 Azitra Profile
  • 7.8.2 Azitra Main Business
  • 7.8.3 Azitra Skin Microbiome Modulator Products, Services and Solutions
  • 7.8.4 Azitra Skin Microbiome Modulator Revenue (US$ Million) & (2020-2025)
  • 7.8.5 Azitra Recent Developments
• 7.9 GALLINEE
  • 7.9.1 GALLINEE Profile
  • 7.9.2 GALLINEE Main Business
  • 7.9.3 GALLINEE Skin Microbiome Modulator Products, Services and Solutions
  • 7.9.4 GALLINEE Skin Microbiome Modulator Revenue (US$ Million) & (2020-2025)
  • 7.9.5 GALLINEE Recent Developments
• 7.10 Glowbiotics
  • 7.10.1 Glowbiotics Profile
  • 7.10.2 Glowbiotics Main Business
  • 7.10.3 Glowbiotics Skin Microbiome Modulator Products, Services and Solutions
  • 7.10.4 Glowbiotics Skin Microbiome Modulator Revenue (US$ Million) & (2020-2025)
  • 7.10.5 Glowbiotics Recent Developments

8 Industry Chain Analysis

• 8.1 Skin Microbiome Modulator Industrial Chain
• 8.2 Skin Microbiome Modulator Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Skin Microbiome Modulator Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Skin Microbiome Modulator Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer